William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 83,900 shares at $81.59 ($6.8M) on 2019-11-12, disclosed to the SEC on 2019-11-13.
Open-market sale of $6.8M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.11 | 29,782 | $2.4M | 35.3% |
| 2 | $80.11 | 29,782 | $2.4M | 35.3% |
| 3 | $81.59 | 11,118 | $907K | 13.4% |
| 4 | $81.59 | 11,118 | $907K | 13.4% |
| 5 | $82.14 | 2,100 | $172K | 2.6% |
| Total | $80.55 avg | 83,900 |
| $6.8M |
| 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |